Glucocorticoids, but not other DMARDs, are associated with a higher risk of severe COVID-
19 outcomes in RA patients. Further studies are needed to explore the impact of specific …

Aim To update previous guidance of the Asia Pacific League of Associations for
Rheumatology (APLAR) on the management of patients with rheumatic and musculoskeletal …

Background/aim: The COVID-19 outbreak is known to increase stress levels of most patients
with chronic diseases. Patients with ankylosing spondylitis (AS) and rheumatoid arthritis …

Objectives This study aimed to explore the impact of the coronavirus disease 2019 (COVID‐
19) pandemic on self‐care of individuals living with rheumatoid arthritis (RA). Methods …

Objective To evaluate the safety and utility of core needle biopsy (CNB) for diagnosis of
salivary gland lymphoma in Sjögren's syndrome (SS). Methods We analyzed data from …

Background: Rheumatoid arthritis (RA) disease activity, associated comorbidities, and
therapy-related side effects impair the physical, social, and emotional dimensions of the …

Objective In a cohort assembled at the start of the pandemic in New York City, objectives of
this longitudinal study were to ascertain whether perspectives about SARS-CoV-2 risks …

OBJECTIVE: Psychological distress caused by the SARS-CoV-2 outbreak has had
deleterious effects on patients with chronic rheumatic disease, as those patients were highly …

Objective The COVID‐19 pandemic has had considerable economic repercussions for
young workers. The current study was undertaken to examine the impact of the pandemic on …

Objective Patients with autoimmune rheumatic diseases (ARDs) are at greater risk of COVID‐
19 infection and hospitalization, increasing the stress and uncertainty already associated …